S&P 500   3,380.16 (+0.18%)
DOW   29,398.08 (-0.09%)
QQQ   234.64 (+0.29%)
S&P 500   3,380.16 (+0.18%)
DOW   29,398.08 (-0.09%)
QQQ   234.64 (+0.29%)
S&P 500   3,380.16 (+0.18%)
DOW   29,398.08 (-0.09%)
QQQ   234.64 (+0.29%)
S&P 500   3,380.16 (+0.18%)
DOW   29,398.08 (-0.09%)
QQQ   234.64 (+0.29%)
Log in

NYSE:AGN - Allergan Stock Price, Forecast & News

$198.32
-0.94 (-0.47 %)
(As of 02/17/2020 02:48 PM ET)
Today's Range
$197.94
Now: $198.32
$199.40
50-Day Range
$186.64
MA: $191.97
$202.10
52-Week Range
$114.27
Now: $198.32
$202.21
Volume3.06 million shs
Average Volume2.67 million shs
Market Capitalization$65.10 billion
P/E RatioN/A
Dividend Yield1.49%
Beta1.7
Allergan plc, a pharmaceutical company, develops, manufactures, and commercializes branded pharmaceutical, device, biologic, surgical, and regenerative medicine products worldwide. The company operates in three segments: US Specialized Therapeutics, US General Medicine, and International. It offers a portfolio of products in various therapeutic areas, including medical aesthetics and dermatology, eye care, neuroscience, urology, gastrointestinal, women's health, and anti-infective therapeutic products. Read More…

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryPharmaceuticals
SectorMedical
CUSIP01849010
Phone862-261-7000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$16.09 billion
Cash Flow$36.32 per share
Book Value$177.28 per share

Profitability

Net Income$-5,271,000,000.00

Miscellaneous

Employees16,900
Market Cap$65.10 billion
Next Earnings Date5/5/2020 (Estimated)
OptionableOptionable

Receive AGN News and Ratings via Email

Sign-up to receive the latest news and ratings for AGN and its competitors with MarketBeat's FREE daily newsletter.


Allergan (NYSE:AGN) Frequently Asked Questions

What is Allergan's stock symbol?

Allergan trades on the New York Stock Exchange (NYSE) under the ticker symbol "AGN."

How often does Allergan pay dividends? What is the dividend yield for Allergan?

Allergan declared a quarterly dividend on Friday, January 24th. Shareholders of record on Friday, February 14th will be given a dividend of $0.74 per share on Friday, March 13th. This represents a $2.96 dividend on an annualized basis and a yield of 1.49%. The ex-dividend date of this dividend is Thursday, February 13th. View Allergan's Dividend History.

How will Allergan's stock buyback program work?

Allergan declared that its board has approved a share buyback program on Tuesday, January 29th 2019, which allows the company to repurchase $2,000,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to repurchase up to 4.1% of its stock through open market purchases. Stock repurchase programs are usually a sign that the company's leadership believes its stock is undervalued.

How were Allergan's earnings last quarter?

Allergan plc (NYSE:AGN) posted its quarterly earnings data on Monday, February, 10th. The company reported $5.22 EPS for the quarter, beating analysts' consensus estimates of $4.57 by $0.65. The firm had revenue of $4.35 billion for the quarter, compared to analyst estimates of $4.09 billion. Allergan had a negative net margin of 32.76% and a positive return on equity of 9.82%. The company's quarterly revenue was up 6.6% on a year-over-year basis. During the same period last year, the firm earned $4.29 EPS. View Allergan's Earnings History.

When is Allergan's next earnings date?

Allergan is scheduled to release their next quarterly earnings announcement on Tuesday, May 5th 2020. View Earnings Estimates for Allergan.

What price target have analysts set for AGN?

19 Wall Street analysts have issued 1 year price objectives for Allergan's shares. Their forecasts range from $144.95 to $203.00. On average, they expect Allergan's share price to reach $178.72 in the next twelve months. This suggests that the stock has a possible downside of 9.9%. View Analyst Price Targets for Allergan.

What is the consensus analysts' recommendation for Allergan?

19 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Allergan in the last year. There are currently 16 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Allergan.

Has Allergan been receiving favorable news coverage?

Media stories about AGN stock have been trending somewhat positive on Monday, according to InfoTrie Sentiment Analysis. The research firm scores the sentiment of news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Allergan earned a daily sentiment score of 1.8 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the next several days. View News Stories for Allergan.

Are investors shorting Allergan?

Allergan saw a increase in short interest in the month of January. As of January 31st, there was short interest totalling 15,400,000 shares, an increase of 5.6% from the January 15th total of 14,580,000 shares. Based on an average trading volume of 2,360,000 shares, the days-to-cover ratio is currently 6.5 days. Approximately 4.7% of the shares of the company are short sold. View Allergan's Current Options Chain.

Who are some of Allergan's key competitors?

What other stocks do shareholders of Allergan own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Allergan investors own include CA (CA), Endologix (ELGX), BlackRock (BLK), Chipotle Mexican Grill (CMG), Athabasca Oil (ATH), Micron Technology (MU), Aegean Marine Petroleum Network (ANW), NIC (EGOV), Transocean (RIG) and United Rentals (URI).

Who are Allergan's key executives?

Allergan's management team includes the folowing people:
  • Mr. Brenton L. Saunders, Chairman, Pres & CEO (Age 49)
  • Mr. William Meury, Exec. VP & Chief Commercial Officer (Age 51)
  • Dr. C. David Nicholson, Exec. VP and Chief R&D Officer (Age 64)
  • Mr. Matthew M. Walsh, Exec. VP & CFO (Age 52)
  • Mr. Wayne R. Swanton, Exec. VP of Global Operations (Age 51)

Who are Allergan's major shareholders?

Allergan's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include State Street Corp (4.39%), Franklin Resources Inc. (2.24%), Longview Partners Guernsey LTD (2.10%), Renaissance Technologies LLC (1.53%), Bank of New York Mellon Corp (0.77%) and TIG Advisors LLC (0.68%). Company insiders that own Allergan stock include Brent L Saunders, Christopher J Coughlin, Joseph H Boccuzi, Maria Teresa Hilado, Matthew M Walsh and William Meury. View Institutional Ownership Trends for Allergan.

Which major investors are selling Allergan stock?

AGN stock was sold by a variety of institutional investors in the last quarter, including Artisan Partners Limited Partnership, Assenagon Asset Management S.A., Fred Alger Management LLC, MUFG Securities EMEA plc, State Street Corp, FMR LLC, Fir Tree Capital Management LP and Commerzbank Aktiengesellschaft FI. View Insider Buying and Selling for Allergan.

Which major investors are buying Allergan stock?

AGN stock was bought by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp, Segantii Capital Management Ltd, Bank of Montreal Can, Beryl Capital Management LLC, Laurion Capital Management LP, FIL Ltd and Vivaldi Asset Management LLC. Company insiders that have bought Allergan stock in the last two years include Brent L Saunders, Christopher J Coughlin, Joseph H Boccuzi, Maria Teresa Hilado and Matthew M Walsh. View Insider Buying and Selling for Allergan.

How do I buy shares of Allergan?

Shares of AGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Allergan's stock price today?

One share of AGN stock can currently be purchased for approximately $198.32.

How big of a company is Allergan?

Allergan has a market capitalization of $65.10 billion and generates $16.09 billion in revenue each year. The company earns $-5,271,000,000.00 in net income (profit) each year or $17.64 on an earnings per share basis. Allergan employs 16,900 workers across the globe.View Additional Information About Allergan.

What is Allergan's official website?

The official website for Allergan is http://www.allergan.com/.

How can I contact Allergan?

Allergan's mailing address is CLONSHAUGH BUSINESS AND TECHNOLOGY PARK COOLOCK, DUBLIN L2, D17 E400. The company can be reached via phone at 862-261-7000 or via email at [email protected]


MarketBeat Community Rating for Allergan (NYSE AGN)

Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  1,372 (Vote Outperform)
Underperform Votes:  683 (Vote Underperform)
Total Votes:  2,055
MarketBeat's community ratings are surveys of what our community members think about Allergan and other stocks. Vote "Outperform" if you believe AGN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AGN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/17/2020 by MarketBeat.com Staff

Featured Article: What is Liquidity?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel